Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEMOXIA-02: Hepatic Arterial Infusion of Gemcitabine-oxaliplatin in Intra-hepatic Cholangiocarcinoma
NCT03364530Phase 2Recruiting
- Sponsor
- CHU Montpellier
- Start
- Jun 2018
- Primary completion
- Oct 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, oxaliplatin in intrahepatic cholangiocarcinoma (ICC), sponsored by CHU Montpellier. Started Jun 2018; status: recruiting.
02
Drugs
gemcitabineoxaliplatin
03
Conditions
intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on NCT03364530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03364530.